PDA Statement Regarding COVID-19 and the 2020 PDA Annual Meeting
PDA has implemented a set of measures to protect participants at PDA events from potential risks related to COVID-19 as best as possible. This includes a close and regular monitoring of the situation, adherence to recommendations of health authorities and official travel warnings, possibilities of remote presentations, and precautions being implemented at our venues.
Regarding the 2020 PDA Annual Meeting, we have been following the situation very closely. In light of the situation with a growing number of our participants not being able to travel, the 2020 PDA Annual Meeting will now be a fully virtual event. All registrations will be transferred to the new dates without penalty. The website will be updated shortly.
We recognize the challenge this may cause, and we apologize for the inconvenience. Like you, we are trying to respond to the changing situation.
The theme of the 2020 meeting is Enhancing the Future with Innovative Medicines and Manufacturing. In selecting this theme, the planning committee designed a comprehensive event that encompasses the wide-ranging interests of all PDA members. Whether you are focused on improving existing processes or delving into entirely new technologies, the PDA Annual Meeting will cover relevant information important to small molecule, and biopharmaceutical, cell and gene therapy and other modalities.
Plenary sessions will inspire all of us to engage as we focus on the importance of what we do every day to improve the quality of life for millions of people. It is a daunting and empowering task we are faced with and these sessions will focus on key aspects of our work including getting personal with patients, understanding regulations, leveraging breakthrough designations, modernizing facilities, strategies for developing next generation medicines, and protecting integrated systems from external threats. Concurrent session tracks include, Developing New Modalities, Targeting Real-Time and Parametric Release, Engineering Data Solutions, and Modernizing Products and Manufacturing.
Rounding out the program are Interest Group sessions, which offer participants a chance to hear from experts as well as engage in interactive discussions on a variety of important topics and specific disciplines.
The virtual exhibition hall provides opportunities for one-on-one interactions with service providers and vendors who will showcase their latest services and technologies. Authors of numerous poster presentations will also be present to discuss their latest research and data. Breaks are scheduled throughout the meeting to allow time for further virtual networking and peer-to-peer discussions.
This virtual meeting is a ‘must attend’ knowledge sharing event for everyone, from corporate executives to those who have recently joined the industry, it is an ideal opportunity to accelerate your impact and position in your company as well as in the pharmaceutical industry.